InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,451.20
(
0.18%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
83.58
(
0.54%
)
Bitcoin
65,499.37
(
2.34%
)
Post# of 14671
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

SAMCMJS

Send PM Follow Ignore
Followers 5
Posts 503
Boards Moderated 0
Alias Born 03/20/2002

SAMCMJS

Re: None

Thursday, 01/30/2003 10:16:37 AM

Thursday, January 30, 2003 10:16:37 AM

Post# of 14671
IBCI Announces Meeting With Federal Agency Concerning Bio-terrorism Set For Monday, February 3, 2003
Thursday January 30, 10:00 am ET
Government Sets Parameters Yesterday Afternoon for Discussion of Combating Bio-terrorism


ATLANTA, Jan. 30 /PRNewswire/ -- International BioChemical Industries, Inc. (OTC Bulletin Board: IBCL - News), formerly known as BioShield Technologies, Inc., announced that a Federal government agency, requesting urgency, has scheduled its meeting with IBCI to discuss test data and BioShield products that will be effective in the war on bio-terrorism. The discussion will include manufacturing capabilities, good laboratory practices and protocols, security of the facility and security of internal data files including test locations and employee confidentiality.
ADVERTISEMENT


About International BioChemical Industries:

International BioChemical Industries, Inc. is a Norcross, Georgia-based emerging growth company with the only antimicrobial technology approved by the EPA for residual kill on hard surfaces up to 28 days. Additional approvals by the EPA include 5 year residual kill in textiles, approval for use in cosmetics and approval for fogging. The company's antimicrobial technology is an alternative to conventional sanitizers, disinfectants, bleaches, biocides or preservatives primarily because it kills bacteria on contact and can remain active for extended time periods. To date IBCI has received four U.S. patents and eight EPA registrations, including the first U.S. germ killer and disinfectant against Salmonella cholerasuis, Staphylococcus aureus and other microorganisms. The company has developed several alliances in different industries, such as healthcare, textiles and storm water.

Further information on IBCI and its line of products can be found by visiting the firm's web site at http://www.bioshield.com , or by calling 1-770-925-3653, Tim Moses.

Safe Harbor/Forward-looking Statements:



Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up